首页> 美国卫生研究院文献>International Journal of Molecular Medicine >MicroRNA-206 overexpression promotes apoptosis induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells
【2h】

MicroRNA-206 overexpression promotes apoptosis induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells

机译:MicroRNA-206过表达促进细胞凋亡诱导细胞周期停滞并抑制人肝细胞癌HepG2细胞的迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNA-206 (miR-206) is known to regulate cell proliferation and migration and is involved in various types of cancer. However, the role of miR-206 in human hepatocellular carcinoma (HHC) has not been previously reported. In the present study, the expression of Notch3 in HCC and adjacent non-neoplastic tissue was immunohistochemically assessed on formalin-fixed, paraffin-embedded sections. miR-206 mimics were transiently transfected into HepG2 cells using Lipofectamine™ 2000. Subsequently, we evaluated the role of miR-206 in cell proliferation, apoptosis, cell cycle arrest and migration by MTS assay, Hoechst 33342 staining, Annexin V-FITC/PI assay, flow cytometry and wound healing assay. Using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot analysis, we detected the expression of Notch3, Bax, Bcl-2, Hes1, p57 and matrix metalloproteinase (MMP)-9 at the mRNA and protein level, respectively. In addition, we measured the expression of miR-206 at the mRNA level and that of caspase-3 at the protein level. After miR-206 was upregulated in HepG2 cells, Notch3, Hes1, Bcl-2 and MMP-9 were downregulated both at the mRNA and protein level, whereas p57 and Bax were upregulated. Cleaved caspase-3 protein expression was also markedly increased. Cell proliferation was significantly attenuated and apoptosis was markedly increased. Furthermore, miR-206 overexpression induced cell cycle arrest and inhibited the migration of HepG2 cells. Taken together, our results uggest that miR-206 is a potential regulator of apoptosis, the cell cycle and migration in HepG2 cells and that it has the potential for use in the targeted therapy of HCC and is a novel tumor suppressor.
机译:已知MicroRNA-206(miR-206)调节细胞增殖和迁移,并参与各种类型的癌症。但是,miR-206在人类肝细胞癌(HHC)中的作用尚未见报道。在本研究中,在福尔马林固定,石蜡包埋的切片上通过免疫组织化学方法评估了Notch3在肝癌和邻近非肿瘤组织中的表达。使用Lipofectamine™2000将miR-206模拟物瞬时转染到HepG2细胞中。随后,我们通过MTS分析,Hoechst 33342染色,膜联蛋白V-FITC / PI评估了miR-206在细胞增殖,凋亡,细胞周期阻滞和迁移中的作用。检测,流式细胞术和伤口愈合检测。使用定量逆转录聚合酶链反应(qRT-PCR)和蛋白质印迹分析,我们分别在mRNA和蛋白水平检测到Notch3,Bax,Bcl-2,Hes1,p57和基质金属蛋白酶(MMP)-9的表达。此外,我们在mRNA水平上测量了miR-206的表达,在蛋白水平上测量了caspase-3的表达。在HepG2细胞中上调miR-206后,Notch3,Hes1,Bcl-2和MMP-9在mRNA和蛋白质水平上均被下调,而p57和Bax被上调。劈裂的caspase-3蛋白表达也明显增加。细胞增殖显着减弱,凋亡明显增加。此外,miR-206过表达诱导细胞周期停滞并抑制HepG2细胞的迁移。综上所述,我们的结果表明miR-206是HepG2细胞凋亡,细胞周期和迁移的潜在调节剂,并且具有用于HCC靶向治疗的潜力,并且是一种新型的肿瘤抑制因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号